Effect of Cosmos caudatus (Ulam raja) supplementation in patients with type 2 diabetes: study protocol for a randomized controlled trial

• Main Authors: Cheng, Shi Hui, Ismail, Amin, Anthony, Joseph, Ooi, Chuan Ng, Abdul Hamid, Azizah, Mohd Yusof, Barakatun Nisak
• Format: Article
• Language: English
• Published: BioMed Central 2016
• Online Access: http://psasir.upm.edu.my/id/eprint/55599/1/Effect%20of%20Cosmos%20caudatus%20%28Ulam%20raja%29.pdf; http://psasir.upm.edu.my/id/eprint/55599/

BACKGROUND: Type 2 diabetes mellitus is a major health threat worldwide. Cosmos caudatus is one of the medicinal plants used to treat type 2 diabetes. Therefore, this study aims to determine the effectiveness and safety of C. caudatus in patients with type 2 diabetes. Metabolomic approach will be carried out to compare the metabolite profiles between C. Caudatus treated diabetic patients and diabetic controls. METHODS AND DESIGN: This is a single-center, randomized, controlled, two-arm parallel design clinical trial that will be carried out in a tertiary hospital in Malaysia. In this study, 100 patients diagnosed with type 2 diabetes will be enrolled. Diabetic patients who meet the eligibility criteria will be randomly allocated to two groups, which are diabetic C. caudatus treated(U) group and diabetic control (C) group. Primary and secondary outcomes will be measured at baseline, 4, 8, and 12 weeks. The serum and urine metabolome of both groups will be examined using proton NMR spectroscopy. DISCUSSION: The study will be the first randomized controlled trial to assess whether C. caudatus can confer beneficial effect in patients with type 2 diabetes. The results of this trial will provide clinical evidence on the effectiveness and safety of C. caudatus in patients with type 2 diabetes.